Kamran Alam - May 31, 2023 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role: Chief Financial Officer
Signature: /s/ Kamran Alam
Stock symbol: TSHA
Transactions as of: May 31, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/2/2023, 04:12 PM
Previous filing: Feb 6, 2023
Next filing: Aug 25, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TSHA	Common Stock	Award		+6.23K	+2.19%		291K	May 31, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a performance restricted stock unit ("PRSU") award. The PRSUs were awarded on February 2, 2023 by the Compensation Committee (the "Compensation Committee") of the Issuer's Board of Directors as annual incentive compensation for 2022 performance. On May 31, 2023, the Compensation Committee certified the achievement of a certain performance goal. The PRSUs covered by this report vested upon certification.
F2	Each PRSU represented a contingent right to receive one share the Issuer's common stock.

Content

Represents a performance restricted stock unit ("PRSU") award. The PRSUs were awarded on February 2, 2023 by the Compensation Committee (the "Compensation Committee") of the Issuer's Board of Directors as annual incentive compensation for 2022 performance. On May 31, 2023, the Compensation Committee certified the achievement of a certain performance goal. The PRSUs covered by this report vested upon certification.

Each PRSU represented a contingent right to receive one share the Issuer's common stock.